STEERING COMMITEE
CORE MANAGEMENT | |||
SIRIC |
SIRIC |
SIRIC Financial |
Patient |
![]() |
![]() |
![]() |
![]() |
Eric DEUTSCH |
Alexandre BOBARD |
Matthieu PETIT-KELLER |
Olivier LECOMTE |
SCIENTIFC LEADERS | |||||||||
WP1: DNA Damage Response |
WP2: Immuno-Oncology and Tumor Micro-Environment |
WP3: Cancer Molecular Dynamics, |
|||||||
![]() |
![]() |
![]() |
|||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||
Patricia KANNOUCHE |
Sophie POSTEL-VINAY |
Laurence ZITVOGEL |
Jean-Yves SCOAZEC |
Olivier BERNARD |
Fabrice ANDRE |
Ines VAZ-LUIS |
The steering committee gathers monthly and is in charge of :
- program progresses monitoring
- next investments prioritization (human resources and equipment)
- auditions of promising technologies to implement
- call for proposal setting-up and diffusion
- valorization, troubleshooting and brainstorming on novel approaches to tackle cancer
- dissemination plan development (conferences, seminars, symposiums…)
- educational actions setting-up (degrees, trainings, workshops, master-class…)
- new scientific orientations to carry out